Underlying diseases | Patients n (%) | CDT pos n (%) | CDT neg n (%) | Chi-square p-value |
---|---|---|---|---|
Pancreatic diseases | 340 (16.7) | 104 (30.6) | 236 (69.4) | <Â 0.05* |
Hepatic diseases | 245 (12.0) | 48 (19.6) | 197 (80.4) | |
Renal diseases | 408 (20.0) | 73 (17.9) | 335 (82.1) | |
Malignancies | 517 (25.4) | 110 (21.3) | 407 (78.7) | |
Miscellaneous diseases | 526 (25.9) | 105 (20) | 421 (80) | |
Total | 2036 (100) | 440 (21.6) | 1596 (78.4) | Â |
Post Hoc analysis* Adjusted p-value* | Pancreatic diseases | Hepatic diseases | <Â 0.05* | |
Renal diseases | ||||
Malignancies | ||||
Miscellaneous diseases | ||||
Hepatic diseases | Renal diseases | 0.71 | ||
Miscellaneous diseases | 0.92 | |||
Malignancies | Hepatic diseases | 0.71 | ||
Renal diseases | 0.42 | |||
Miscellaneous diseases | 0.71 | |||
Miscellaneous diseases | Renal diseases | 0.71 |